These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27135149)
1. The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention. Adam Z; Turley A; Mason JM; Kasim AS; Newby D; Mills N; Padfield G; Thompson L; Morley R; Hall JA; Wright RA; Muir DF; Sutton AG; Swanson N; Carter J; Bilous R; Jones S; de Belder MA Int J Cardiol; 2016 Aug; 216():1-8. PubMed ID: 27135149 [TBL] [Abstract][Full Text] [Related]
2. Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent. Silenzi S; Grossi P; Mariani L; Fraccaro C; Vagnarelli F; Moretti L J Interv Cardiol; 2016 Jun; 29(3):300-10. PubMed ID: 27242170 [TBL] [Abstract][Full Text] [Related]
3. A randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based Zotarolimus-Eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety & effectiveness of drug-eluting stents & anti-platelet regimen), a randomized, controlled, noninferiority trial. Park KW; Kang SH; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Hur SH; Ryu JK; Lee BR; Park YW; Chae IH; Kim HS; J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2805-16. PubMed ID: 24814486 [TBL] [Abstract][Full Text] [Related]
4. Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis. Nakajima Y; Itoh T; Morino Y Catheter Cardiovasc Interv; 2016 Mar; 87(4):E137-42. PubMed ID: 26011018 [TBL] [Abstract][Full Text] [Related]
5. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions. Coroleu SF; De Vita M; Burzotta F; Trani C; Porto I; Niccoli G; Leone AM; Tommasino A; Talarico GP; Schiavoni G; Crea F EuroIntervention; 2012 Oct; 8(6):701-7. PubMed ID: 23086788 [TBL] [Abstract][Full Text] [Related]
6. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial. Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449 [TBL] [Abstract][Full Text] [Related]
7. Real world experience with an indigenously manufactured stent Cobal C--a retrospective study. Sastry BK; Kumar N; Menon R; Kapadia A; Sridevi C; Surya Prakash G; Krishna Reddy N; Srinivasa Rao M Indian Heart J; 2014; 66(5):525-9. PubMed ID: 25443606 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. Ali RM; Degenhardt R; Zambahari R; Tresukosol D; Ahmad WA; Kamar Hb; Kui-Hian S; Ong TK; bin Ismail O; bin Elis S; Udychalerm W; Ackermann H; Boxberger M; Unverdorben M EuroIntervention; 2011 May; 7 Suppl K():K83-92. PubMed ID: 22027736 [TBL] [Abstract][Full Text] [Related]
9. The Outcome of Percutaneous Coronary Intervention for Significant Atherosclerotic Lesions in Segment Proximal to Myocardial Bridge at Left Anterior Descending Coronary Artery. Hao Z; Xinwei J; Ahmed Z; Huanjun P; Zhanqi W; Yanfei W; Chunhong C; Chan Z; Liqiang F Int Heart J; 2018 May; 59(3):467-473. PubMed ID: 29681571 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization. Ortolani P; Marzocchi A; Marrozzini C; Palmerini T; Saia F; Taglieri N; Aquilina M; Baldazzi F; Silenzi S; Cooke RM; Reggiani ML; Branzi A Catheter Cardiovasc Interv; 2007 May; 69(6):790-8. PubMed ID: 17290437 [TBL] [Abstract][Full Text] [Related]
11. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients. Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW; JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017 [TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). Wojakowski W; Pyrlik A; Król M; Buszman P; Ochała A; Milewski K; Smolka G; Kawecki D; Rudnik A; Pawłowski T; Jadczyk T; Wyderka R; Cybulski W; Dworowy S; Tendera M Minerva Cardioangiol; 2013 Jun; 61(3):301-11. PubMed ID: 23681133 [TBL] [Abstract][Full Text] [Related]
13. Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease. Abreu Filho LM; Forte AA; Sumita MK; Favarato D; Meireles GC Clinics (Sao Paulo); 2011; 66(6):985-9. PubMed ID: 21808863 [TBL] [Abstract][Full Text] [Related]
14. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1. Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447 [TBL] [Abstract][Full Text] [Related]
15. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057 [TBL] [Abstract][Full Text] [Related]
16. Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: results of the real world Coroflex Blue Registry. Bocksch W; Pomar F; Dziarmaga M; Tresukosol D; Ismail O; Janek B; Carlsson J; Simon JP; Catheter Cardiovasc Interv; 2010 Jan; 75(1):78-85. PubMed ID: 19739262 [TBL] [Abstract][Full Text] [Related]
17. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry. Jensen JK; Jensen LO; Terkelsen CJ; Lassen JF; Tilsted HH; Hansen KN; Maeng M; Thuesen L; Thayssen P Catheter Cardiovasc Interv; 2013 Feb; 81(2):260-5. PubMed ID: 22511512 [TBL] [Abstract][Full Text] [Related]
18. Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: a prospective registry. Koh AS; Choi LM; Sim LL; Tan JW; Khin LW; Chua TS; Koh TH; Chia S Acute Card Care; 2011 Dec; 13(4):219-22. PubMed ID: 22142201 [TBL] [Abstract][Full Text] [Related]
19. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607 [TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents. De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]